EMEA-000977-PIP01-10 - paediatric investigation plan

EMEA-000977-PIP01-10 - paediatric investigation plan house dust mites allergen extract from Dermatophagoides pteronyssinus and Dermatophagoides farinae (50/50) PIP Human Key facts Active substance house dust mites allergen extract from Dermatophagoides pteronyssinus and Dermatophagoides farinae (50/50) Therapeutic area Pneumology-allergology Decision number P/34/2011 PIP number EMEA-000977-PIP01-10 Pharmaceutical form(s) Oral solution Condition(s) / indication(s) Treatment of allergic rhinitis / rhino-conjunctivitis Route(s) of administration Sublingual use Contact for public enquiries Stallergenes S.A. pip.germany@stallergenes.fr France Phone: +33 155592100 Fax: +33 155592002 Decision type P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) Decision date 28/01/2011 Compliance check done No Decision P/34/2011: EMA decision of 28 January 2011 on the agreement of a paediatric investigation plan and on the granting of a deferral and on the granting of a waiver for house dust mites allergen extract from Dermatophagoide... Adopted Reference Number: EMA/58433/2011 English (EN) (74.21 KB - PDF) First published: 24/02/2011 Last updated: 24/02/2011 View Related content House dust mites allergen extract from Dermatophagoides pteronyssinus and Dermatophagoides farinae (50/50) : Notification of discontinuation of a paediatric development which is covered by an agreed PIP Decision English (EN) (85.56 KB - PDF) First published: 25/03/2026 View Share this page